Russian doctors unveil new Alzheimer’s treatment using unique technique

Sechenov Medical University in Moscow has announced that doctors at its Third University Clinical Hospital have introduced a new treatment strategy for Alzheimer’s patients, utilizing a selective plasma DNA adsorption technique. The university described this approach as the first of its kind globally.

The university explained that the technique is an extracorporeal therapy, targeting and binding DNA-containing structures from blood plasma. This method fundamentally differs from conventional plasma separation procedures.

The treatment course consisted of three sessions, spaced two to three days apart. During each session, an amount equivalent to 200% of the circulating plasma volume was processed, with patients undergoing examinations before and after the treatment.

Positive preliminary results after three months of treatment

The university reported positive results three months after treatment, including improvements in episodic verbal memory, information processing speed, and attention, as well as better performance in certain cognitive functions according to neuropsychological assessments.

Alzheimer’s disease is among the most common neurodegenerative disorders, and medical research continues to seek therapies that slow its progression and improve patients’ quality of life.